|Daiichi Sankyo Company Limited -- USA Stock|| |
USD 33.83 0.000002 0.00%
Executive Officer, Manager of Tokyo Office in Main Medical Sales Unit of Japan Company
We currently do not have informatin regarding Shinichi Terano. This executive tanure with Daiichi Sankyo Company Limited is not currenlty determined.
Executive Since 2015
81 3 6225 1111 http://www.daiichisankyo.com
The company has return on total asset (ROA)
of 1.7 %
which means that it generated profit of $1.7 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of 2.66 %
meaning that it generated $2.66 on every $100 dollars invested by stockholders.
The company has accumulated 2.64 B in total debt with debt to equity ratio (D/E) of 23.3 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Daiichi Sankyo Company Limited has Current Ratio of 3.59 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
Daiichi Sankyo Company, Limited researches, develops, manufactures, imports, and markets pharmaceutical products worldwide. The company was founded in 1899 and is headquartered in Tokyo, Japan. Daiichi Sankyo is traded on OTC Market in USA.Daiichi Sankyo Company Limited (DSNKY) is traded on OTC Market in USA. It is located in 3-5-1, Nihonbashi-honcho and employs 14,670 people.